Elucidating the specific pharmacological mechanism of action (MOA) of naturally transpiring compounds is often demanding. Although Tarselli et al. (60) developed the initial de novo synthetic pathway to conolidine and showcased that this naturally occurring compound successfully suppresses responses to both chemically induced and inflammation-derived pain, the pharmacologic concentrate https://bookmark-search.com/story20735638/an-unbiased-view-of-alternative-natural-pain-relief-to-replace-traditional-painkillers